Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?

K Mc Namara, H Alzubaidi… - … pharmacy research and …, 2019 - Taylor & Francis
Cardiovascular diseases (CVDs) are a leading cause of death globally. This article explores
the evidence surrounding community pharmacist interventions to reduce cardiovascular …

Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: an umbrella review

A San-Juan-Rodriguez, TV Newman, I Hernandez… - Preventive …, 2018 - Elsevier
Preventable diseases and late diagnosis of disease impose great clinical and economic
burden for health care systems, especially in the current juncture of rising medical …

Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk

MA Strand, H Eukel, S Burck - Research in Social and Administrative …, 2019 - Elsevier
Background Prescription opioids are known to be highly addictive, contributing to the opioid
epidemic which continues to besiege victims in the United States. Pharmacists are …

The impact of clinical services provided by community pharmacies on the Australian healthcare system: a review of the literature

VH Buss, A Shield, S Kosari… - Journal of Pharmaceutical …, 2018 - Taylor & Francis
Abstract Background In Australia, community pharmacists are increasingly being integrated
into the healthcare system. A range of services in pharmacies are government-funded …

Pharmaceutical services cost analysis using time-driven activity-based costing: A contribution to improve community pharmacies' management

J Gregório, G Russo, LV Lapão - Research in Social and Administrative …, 2016 - Elsevier
Background The current financial crisis is pressing health systems to reduce costs while
looking to improve service standards. In this context, the necessity to optimize health care …

A cross-sectional survey of enhanced and extended professional services in community pharmacies: a pharmacy perspective

TF Sim, B Wright, L Hattingh, R Parsons… - Research in Social and …, 2020 - Elsevier
Background Community pharmacies provide enhanced (within current scope of practice)
and extended (requiring additional credentialing) services, for disease state management …

Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional …

CE Amadi, FO Lawal, AC Mbakwem… - International journal of …, 2018 - Springer
Background Studies in international literature have shown that Community Pharmacists can
make considerable impact in controlling cardiovascular disease risk factors, especially …

Successful implementation and provision of enhanced and extended pharmacy services

L Hattingh, TF Sim, B Sunderland, P Czarniak - Research in Social and …, 2020 - Elsevier
Background Careful planning is important for successful implementation and ongoing
provision of enhanced and extended pharmacy services. Objective To explore the factors …

Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery

A Bachyrycz, S Shrestha, BE Bleske… - Substance …, 2017 - journals.sagepub.com
Background: Given that opioid misuse/abuse and opioid overdose have reached epidemic
proportions in the United States, expansion of naloxone access programs are desperately …

Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in …

I Krass, R Carter, B Mitchell, M Mohebbi… - Diabetes Research and …, 2023 - Elsevier
Aims To compare the effectiveness of three pharmacy-based screening methods for type 2
diabetes (T2DM):(1) risk assessment (AUSDRISK) alone (Group A); AUSDRISK followed by …